Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 6, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc.
| -14.70K |
$4.31 | -$63,392.65 | -5.98% | 231.01K | +1 |
Mar 4 - Mar 5
| ||||||
Vanda Pharmaceuticals Inc.
| 125K |
—
|
—
| +103.55% | 245.71K | +1 |
Feb 16
| ||||||
Vanda Pharmaceuticals Inc.
| -2.21K |
$6.30 | -$13,944.60 | -1.80% | 120.71K | +1 |
Jul 28
| ||||||
Vanda Pharmaceuticals Inc.
| -16.00K |
$6.29 | -$100,710.40 | -11.52% | 122.93K | +1 |
Jun 15
| ||||||
Vanda Pharmaceuticals Inc.
| -13.93K |
$6.27 | -$87,344.39 | -9.12% | 138.93K | +1 |
Mar 2 - Mar 3
| ||||||
Vanda Pharmaceuticals Inc.
| 32.7K |
—
|
—
| +27.21% | 152.86K | +1 |
Feb 16
| ||||||
Vanda Pharmaceuticals Inc.
| 2.71K |
$6.87 | -$27,426.83 | +2.31% | 120.16K | +1 |
Dec 6
| ||||||
Vanda Pharmaceuticals Inc.
| -2.24K |
$10.97 | -$24,561.83 | -1.87% | 117.45K | +1 |
Jul 28
| ||||||
Vanda Pharmaceuticals Inc.
| 20.39K |
$11.26 | -$138,512.56 | +20.54% | 119.69K | +1 |
Feb 28 - Mar 2
| ||||||
Vanda Pharmaceuticals Inc.
| -2.13K |
$19.24 | -$40,972.89 | -2.10% | 99.3K | +1 |
Jul 28
| ||||||
Vanda Pharmaceuticals Inc.
| -9.37K |
$18.35 | -$171,970.64 | -8.46% | 101.43K | +1 |
Mar 1 - Mar 2
| ||||||
Vanda Pharmaceuticals Inc.
| 32.7K |
—
|
—
| +41.87% | 110.8K | +1 |
Feb 24
| ||||||
Vanda Pharmaceuticals Inc.
| 17.34K |
—
|
—
| +28.55% | 78.1K | +1 |
Jul 27
| ||||||
Vanda Pharmaceuticals Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||